Corcept Therapeutics, Inc. (CORT)
72.77
+1.14
(+1.59%)
USD |
NASDAQ |
Nov 06, 16:00
72.76
-0.01
(-0.01%)
After-Hours: 20:00
Corcept Therapeutics Cash from Investing (Quarterly) : -131.99M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -131.99M |
| June 30, 2026 | -29.24M |
| March 31, 2026 | 4.542M |
| December 31, 2025 | -11.84M |
| September 30, 2025 | 14.64M |
| June 30, 2025 | 70.13M |
| March 31, 2025 | -3.171M |
| December 31, 2024 | -64.36M |
| September 30, 2024 | -44.04M |
| June 30, 2024 | -60.19M |
| March 31, 2024 | -9.014M |
| December 31, 2023 | 17.10M |
| September 30, 2023 | -109.57M |
| June 30, 2023 | -24.10M |
| March 31, 2023 | 207.48M |
| December 31, 2022 | -17.24M |
| September 30, 2022 | -4.79M |
| June 30, 2022 | -41.80M |
| March 31, 2022 | -50.50M |
| December 31, 2021 | 140.47M |
| September 30, 2021 | -25.80M |
| June 30, 2021 | 24.74M |
| March 31, 2021 | -3.284M |
| December 31, 2020 | 11.22M |
| September 30, 2020 | -64.27M |
| Date | Value |
|---|---|
| June 30, 2020 | -85.94M |
| March 31, 2020 | 19.73M |
| December 31, 2019 | -61.99M |
| September 30, 2019 | -54.32M |
| June 30, 2019 | -1.156M |
| March 31, 2019 | -0.367M |
| December 31, 2018 | -1.757M |
| September 30, 2018 | -33.51M |
| June 30, 2018 | -21.21M |
| March 31, 2018 | -34.29M |
| December 31, 2017 | -27.45M |
| September 30, 2017 | -11.65M |
| June 30, 2017 | -14.95M |
| March 31, 2017 | -19.41M |
| December 31, 2016 | -0.075M |
| September 30, 2016 | -0.09M |
| June 30, 2016 | -0.007M |
| March 31, 2016 | -0.022M |
| December 31, 2015 | 0.017M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.034M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.016M |
| June 30, 2014 | -0.048M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.026B |
| Phibro Animal Health Corp. | -- |
| Illumina, Inc. | 50.00M |
| Eli Lilly & Co. | -8.299B |
| Merck & Co., Inc. | -1.319B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 142.89M |
| Cash from Financing (Quarterly) | -23.88M |
| Free Cash Flow | 194.62M |
| Free Cash Flow Per Share (Quarterly) | 1.154 |
| Free Cash Flow to Equity (Quarterly) | 142.61M |
| Free Cash Flow to Firm (Quarterly) | 142.18M |
| Free Cash Flow Yield | 2.30% |